The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.
Official Title: A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTERE™) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy.
Study ID: NCT00047840
Brief Summary: The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Los Angeles, California, United States
Research Site, Jacksonville, Florida, United States
Research Site, Atlanta, Georgia, United States
Research Site, New Orleans, Louisiana, United States
Research Site, Boston, Massachusetts, United States
Research Site, Pittsfield, Massachusetts, United States
Research Site, Ann Arbor, Michigan, United States
Research Site, Detroit, Michigan, United States
Research Site, Billings, Montana, United States
Research Site, Great Neck, New York, United States
Research Site, New York, New York, United States
Research Site, Durham, North Carolina, United States
Research Site, Coos Bay, Oregon, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Pittsburgh, Pennsylvania, United States
Research Site, Houston, Texas, United States
Research Site, Brno, , Czech Republic
Research Site, Chomutov, , Czech Republic
Research Site, Hradec, , Czech Republic
Research Site, Ostrava, , Czech Republic
Research Site, Plzen, , Czech Republic
Research Site, Praha, , Czech Republic
Research Site, Budapest, , Hungary
Research Site, Debrecen, , Hungary
Research Site, Deszk, , Hungary
Research Site, Torokbalint, , Hungary
Name: Clinical Sciences & Operations
Affiliation: Sanofi
Role: STUDY_DIRECTOR